Exosomes Market

CHAPTER 1. Industry Overview of Exosomes Market

1.1. Definition and Scope

1.1.1. Definition of Exosomes

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global ExosomesMarket

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Exosomes MarketByWorkflow

1.2.3. ExosomesMarketByBiomolecule Type

1.2.4. ExosomesMarketByApplication

1.2.5. ExosomesMarketBy Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Exosomes Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Exosomes Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2021

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of ExosomesMajor Manufacturers in 2021

CHAPTER 5. Exosomes Market By Workflow

5.1. Introduction

5.2. Exosomes Market Revenue ByWorkflow

5.2.1. Exosomes Market Revenue (US$ Mn) and Forecast, By Workflow, 2018-2030

5.2.2. Downstream Analysis

5.2.2.1. Downstream AnalysisMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.2.2. Protein Analysis Using Blotting & ELISA

5.2.2.2.1. Protein Analysis Using Blotting & ELISAMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.2.3. Cell Surface Marker Analysis using Flow Cytometry

5.2.2.3.1. Cell Surface Marker Analysis using Flow CytometryMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.2.4. Proteomic Analysis Using Mass Spectrometry

5.2.2.4.1. Proteomic Analysis Using Mass SpectrometryMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.2.5. RNA Analysis with NGS & PCR

5.2.2.5.1. RNA Analysis with NGS & PCRMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.2.6. Others

5.2.2.6.1. OthersMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.3. Isolation Methods

5.2.3.1. Isolation MethodsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.3.2. Ultracentrifugation

5.2.3.2.1. UltracentrifugationMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.3.3. Precipitation

5.2.3.3.1. PrecipitationMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.3.4. Immunocapture on Beads

5.2.3.4.1. Immunocapture on BeadsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.3.5. Filtration

5.2.3.5.1. FiltrationMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

CHAPTER 6. Exosomes Market Revenue By Biomolecule Type

6.1. Introduction

6.2. Exosomes MarketRevenue (US$ Mn)By Biomolecule Type

6.2.1. ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

6.2.2. Non-coding RNAs

6.2.2.1. Non-coding RNAsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.3. Proteins /Peptides

6.2.3.1. Proteins /PeptidesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.4. mRNA

6.2.4.1. mRNAMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.5. DNA fragments

6.2.5.1. DNA fragmentsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.6. Lipids

6.2.6.1. LipidsMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

CHAPTER 7. Exosomes Market Revenue By Application

7.1. Introduction

7.2. ExosomesMarket Revenue (US$ Mn) By Application

7.2.1. ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

7.2.2. Cancer

7.2.2.1. CancerMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

7.2.3. Cardiovascular Diseases

7.2.3.1. Cardiovascular DiseasesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

7.2.4. Neurodegenerative Diseases

7.2.4.1. Neurodegenerative DiseasesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

7.2.5. Infectious Diseases

7.2.5.1. Infectious DiseasesMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

7.2.6. Others

7.2.6.1. OthersMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030

CHAPTER 8. North America Exosomes Market By Country 

8.1. North America ExosomesMarket Overview

8.2. U.S.

8.2.1. U.S.ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

8.2.2. U.S.ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

8.2.3. U.S.ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

8.3. Canada

8.3.1. Canada ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

8.3.2. Canada ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

8.3.3. Canada ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

8.4. North America PEST Analysis

CHAPTER 9. Europe Exosomes Market By Country

9.1. Europe ExosomesMarket Overview

9.2. U.K.

9.2.1. U.K.ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

9.2.2. U.K.ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

9.2.3. U.K.ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

9.3. Germany

9.3.1. GermanyExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

9.3.2. GermanyExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

9.3.3. GermanyExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

9.4. France

9.4.1. FranceExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

9.4.2. FranceExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

9.4.3. FranceExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

9.5. Spain

9.5.1. SpainExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

9.5.2. SpainExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

9.5.3. SpainExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

9.6. Rest of Europe

9.6.1. Rest of EuropeExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

9.6.2. Rest of EuropeExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

9.6.3. Rest of EuropeExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

9.7. Europe PEST Analysis

CHAPTER 10. Asia-Pacific Exosomes Market By Country

10.1. Asia-Pacific ExosomesMarket Overview

10.2. China

10.2.1. ChinaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

10.2.2. ChinaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

10.2.3. ChinaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

10.3. Japan

10.3.1. JapanExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

10.3.2. JapanExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

10.3.3. JapanExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

10.4. India

10.4.1. IndiaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

10.4.2. IndiaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

10.4.3. IndiaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

10.5. Australia

10.5.1. AustraliaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

10.5.2. AustraliaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

10.5.3. AustraliaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

10.6. South Korea

10.6.1. South KoreaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

10.6.2. South KoreaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

10.6.3. South KoreaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-PacificExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

10.7.2. Rest of Asia-PacificExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

10.7.3. Rest of Asia-PacificExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Exosomes Market By Country

11.1. Latin AmericaExosomesMarket Overview

11.2. Brazil

11.2.1. BrazilExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

11.2.2. BrazilExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

11.2.3. BrazilExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

11.3. Mexico

11.3.1. MexicoExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

11.3.2. MexicoExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

11.3.3. MexicoExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

11.4. Rest of Latin America

11.4.1. Rest of Latin AmericaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

11.4.2. Rest of Latin AmericaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

11.4.3. Rest of Latin AmericaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Exosomes Market By Country 

12.1. Middle East & Africa ExosomesMarket Overview

12.2. GCC

12.2.1. GCCExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

12.2.2. GCCExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

12.2.3. GCCExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

12.3. South Africa

12.3.1. South AfricaExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

12.3.2. South AfricaExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

12.3.3. South AfricaExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa ExosomesMarket Revenue (US$ Mn) and Forecast ByWorkflow, 2018-2030

12.4.2. Rest of Middle East & Africa ExosomesMarket Revenue (US$ Mn) and Forecast ByBiomolecule Type, 2018-2030

12.4.3. Rest of Middle East & Africa ExosomesMarket Revenue (US$ Mn) and Forecast ByApplication, 2018-2030

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Exosomes Market

13.1. ExosomesMarket Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. Product Launches and ProductEnhancements

13.2.3. Mergers And Acquisition InGlobal ExosomesMarket

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Thermo Fisher Scientific, Inc.

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Market Revenue (US$ Mn), 2021

14.1.3.2. Thermo Fisher Scientific, Inc.2021Exosomes Business Regional Distribution

14.1.4. Product/service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Qiagen

14.3. Hitachi Chemical Diagnostics Inc.

14.4. Fujifilm

14.5. Danaher

14.6. Illumina, Inc.

14.7. Lonza

14.8. Takara Bio Company

14.9. MiltenyiBiotec

14.10. Malvern Instruments Ltd.

14.11. System Biosciences Inc.

14.12. MBL International Corporation